The drastic decrease in mammosphere formation rates observed following treatment of MCF-7 and MCF-7/HER2 cancer cell populations with Soraphen A certainly provided preliminary insight as to the Soraphen A's mechanism of action, in particular to its putative ability to specifically remove CSCs from the bulk population. Here, ERBB2 is linked to cancer.